论文信息 - Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG) - 字舞流文

Temozolomide Plus Bevacizumab in Elderly Patients with Newly Diagnosed Glioblastoma and Poor Performance Status: An ANOCEF Phase II Trial (ATAG)

J. Honnorat | D. Frappaz | O. Chinot | K. Mokhtari | J. Delattre | F. Ghiringhelli | M. Tanguy | É. Le Rhun | L. Taillandier | M. Fabbro | J. Guillamo | C. Campello | S. Cartalat‐Carel | I. Tennevet | P. Beauchesne | J. Barrière | M. Barrié | I. Catry-Thomas | G. Reyes‐Botero | A. Benouaich‐Amiel